Trends in places of death across 32 countries during and before the COVID-19.
Safety, efficacy and dosing questions linger for Lilly’s Alzheimer’s drug ahead of Monday adcomm
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS